Ildong Holdings Co Ltd (000230) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ildong Holdings Co Ltd (000230) has a cash flow conversion efficiency ratio of 0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩646.53 Million ≈ $438.15K USD) by net assets (₩347.83 Billion ≈ $235.72 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Ildong Holdings Co Ltd (000230) total market value for the company's overall valuation and market capitalisation.
Ildong Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Ildong Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ildong Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ildong Holdings Co Ltd ranked by their cash flow conversion efficiency. Explore 000230 cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Softcat plc
LSE:SCT
|
0.435x |
|
Element 25 Ltd
AU:E25
|
-0.037x |
|
PB Bankshares Inc
NASDAQ:PBBK
|
0.015x |
|
CTI Traffic Industries Co Ltd
TWO:2230
|
-0.134x |
|
Bengang Steel Plates Co Ltd
SHE:200761
|
-0.080x |
|
Cj Seafood
KO:011150
|
0.171x |
|
Greatland Resources Limited
LSE:GGP
|
0.460x |
|
T&R Biofab Co. Ltd
KQ:246710
|
0.002x |
Annual Cash Flow Conversion Efficiency for Ildong Holdings Co Ltd (1999–2025)
The table below shows the annual cash flow conversion efficiency of Ildong Holdings Co Ltd from 1999 to 2025. View Ildong Holdings Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩345.58 Billion ≈ $234.19 Million |
₩26.86 Billion ≈ $18.21 Million |
0.078x | +14.04% |
| 2024-12-31 | ₩254.00 Billion ≈ $172.13 Million |
₩17.31 Billion ≈ $11.73 Million |
0.068x | +120.05% |
| 2023-12-31 | ₩169.90 Billion ≈ $115.14 Million |
₩-57.77 Billion ≈ $-39.15 Million |
-0.340x | +22.91% |
| 2022-12-31 | ₩169.10 Billion ≈ $114.60 Million |
₩-74.59 Billion ≈ $-50.55 Million |
-0.441x | -164.76% |
| 2021-12-31 | ₩183.34 Billion ≈ $124.25 Million |
₩-30.54 Billion ≈ $-20.70 Million |
-0.167x | -717.76% |
| 2020-12-31 | ₩305.61 Billion ≈ $207.11 Million |
₩8.24 Billion ≈ $5.59 Million |
0.027x | -39.62% |
| 2019-12-31 | ₩321.09 Billion ≈ $217.60 Million |
₩14.34 Billion ≈ $9.72 Million |
0.045x | +18.19% |
| 2018-12-31 | ₩164.95 Billion ≈ $111.78 Million |
₩6.23 Billion ≈ $4.22 Million |
0.038x | +401.14% |
| 2017-12-31 | ₩174.64 Billion ≈ $118.35 Million |
₩-2.19 Billion ≈ $-1.49 Million |
-0.013x | -102.87% |
| 2016-12-31 | ₩106.84 Billion ≈ $72.40 Million |
₩46.64 Billion ≈ $31.61 Million |
0.437x | +172.31% |
| 2015-12-31 | ₩349.98 Billion ≈ $237.18 Million |
₩56.11 Billion ≈ $38.03 Million |
0.160x | +35.63% |
| 2014-12-31 | ₩332.95 Billion ≈ $225.64 Million |
₩39.36 Billion ≈ $26.67 Million |
0.118x | +146.72% |
| 2013-12-31 | ₩326.60 Billion ≈ $221.34 Million |
₩15.65 Billion ≈ $10.60 Million |
0.048x | -15.88% |
| 2012-12-31 | ₩324.42 Billion ≈ $219.85 Million |
₩18.48 Billion ≈ $12.52 Million |
0.057x | -65.41% |
| 2011-12-31 | ₩310.17 Billion ≈ $210.20 Million |
₩51.08 Billion ≈ $34.61 Million |
0.165x | +86.76% |
| 2010-12-31 | ₩295.00 Billion ≈ $199.92 Million |
₩26.01 Billion ≈ $17.63 Million |
0.088x | -50.51% |
| 2009-12-31 | ₩280.27 Billion ≈ $189.94 Million |
₩49.93 Billion ≈ $33.84 Million |
0.178x | +114.85% |
| 2007-12-31 | ₩195.76 Billion ≈ $132.66 Million |
₩16.23 Billion ≈ $11.00 Million |
0.083x | -60.80% |
| 2006-12-31 | ₩172.99 Billion ≈ $117.23 Million |
₩36.60 Billion ≈ $24.80 Million |
0.212x | +60.45% |
| 2005-12-31 | ₩146.78 Billion ≈ $99.47 Million |
₩19.35 Billion ≈ $13.12 Million |
0.132x | -32.30% |
| 2004-12-31 | ₩124.97 Billion ≈ $84.69 Million |
₩24.34 Billion ≈ $16.49 Million |
0.195x | +387.25% |
| 2003-12-31 | ₩105.71 Billion ≈ $71.64 Million |
₩4.23 Billion ≈ $2.86 Million |
0.040x | -73.63% |
| 2002-12-31 | ₩94.84 Billion ≈ $64.27 Million |
₩14.37 Billion ≈ $9.74 Million |
0.152x | -49.07% |
| 2001-12-31 | ₩79.37 Billion ≈ $53.79 Million |
₩23.62 Billion ≈ $16.01 Million |
0.298x | +10.87% |
| 2000-12-31 | ₩66.98 Billion ≈ $45.39 Million |
₩17.98 Billion ≈ $12.18 Million |
0.268x | +40.58% |
| 1999-12-31 | ₩55.81 Billion ≈ $37.82 Million |
₩10.66 Billion ≈ $7.22 Million |
0.191x | -- |
About Ildong Holdings Co Ltd
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more